SEATTLE — Results presented here showed early administration of tranexamic acid may not reduce blood transfusion rates among patients with isolated extracapsular hip fractures.
“For our primary outcome measure, there was no difference in transfusion between the treatment group and our placebo group,” Rachel Honig, MD, said in her presentation at the Orthopaedic Trauma Association Annual Meeting.
Honig, along with his colleagues, randomly assigned 128 isolated extracapsular fractures of the hip (mean age 79 years old; 70% were women) to either IV tranexamic acids or a saline-placebo.
